New jersey

Index
Globenewswire

Alvotech and Teva Announce U.S. FDA Approval of Additional Presentation of SELARSDI™ (ustekinumab-aekn), Expanding its Label to Include Further Indications Approved for Reference Product, Stelara® (ustekinumab)

Globenewswire

Orbcomm Joins Move to -15°C Coalition to Promote Cold Chain Sustainability

Globenewswire

Verisk Welcomes Greg Hendrick to Its Board of Directors